CI

At a glance

ClinicalIndex Comparison Record
N/ANot Yet Recruiting· 24 target
Drug / intervention
Bragg ACV Supplement +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07100977
NCT07100977N/ANot Yet Recruiting

A Randomized, Double-blind, Placebo-controlled, Cross-over Clinical Trial to Investigate the Efficacy of Bragg Apple Cider Vinegar Supplement on Blood Glucose Control in a Healthy Adult Population

Bragg Live Food Products·interventional·Posted Aug 3, 2025·Updated Jan 9, 2026

In Brief

A clinical study evaluating Bragg ACV Supplement and Placebo for Postprandial Glucose and Blood Glucose Concentration. Not yet recruiting, targeting 24 participants across 1 site.

Detailed Summary

The goal of this clinical trial is to evaluate the efficacy of a Bragg ACV supplement on postprandial glucose excursion compared to a placebo following a standardized acute carbohydrate load. Participants will be asked to consume an apple cider vinegar supplement 10 minutes prior to a standardized meal.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada
CollaboratorsKGK Science Inc.

Timeline

N/ANot Yet RecruitingOverdue
2026
First PostedAug 3, 2025
Enrollment StartJan 1, 2026
Primary CompletionJan 1, 2026
Study CompletionFeb 1, 2026
TodayJul 1, 2026
Enrollment to primary: 0 daysPosted 11 months ago

Interventions

Bragg ACV Supplementdietary

Participants will be instructed to consume 1 capsule of either Bragg ACV Supplement or placebo 10 minutes prior to consumption of a standardized meal.

Placeboother

Participants will be instructed to consume 1 capsule of either Bragg ACV Supplement or placebo 10 minutes prior to consumption of a standardized meal.